Organizations Filed Purposes:
1. THE ZACHARY AND ELIZABETH M. FISHER ALZHEIMER'S RESEARCH FOUNDATION IS DEDICATED TO ATTACKING THE SCOURGE OF ALZHEIMER'S DISEASE THROUGH A 3PRONGED ASSAULT FOCUSED ON UNDERSTANDING THE CAUSE OF ALZHEIMER'S DISEASE (AD), IMPROVING THE CARE OF PEOPLE LIVING WITH THE DISEASE TO ENHANCE THEIR QUALITY OF LIFE AND THAT OF THEIR CAREGIVERS AND FAMILIES, AND FINDING A CURE.
THE FOUNDATION FUNDS RESEARCH INTO THE CAUSE, CARE, AND CURE OF ALZHEIMER'S DISEASE AT THE ZACHARY AND ELIZABETH M. FISHER CENTER FOR RESEARCH ON ALZHEIMER'S DISEASE AT THE ROCKEFELLER UNIVERSITY IN NEW YORK THAT WAS UNDER THE DIRECTION OF NOBEL LAUREATE DR. PAUL GREENGARD WHOSE FINDINGS HAVE BEEN THE BASIS FOR MUCH OF TODAY'S ALZHEIMER'S INVESTIGATIONS.
A MAJORITY OF OUR GRANT FUNDING GOES TO THE ZACHARY AND ELIZABETH M. FISHER CENTER FOR RESEARCH ON ALZHEIMER'S DISEASE (THE FISHER CENTER LAB) AT THE ROCKEFELLER UNIVERSITY IN NEW YORK, FOR NEUROLOGICAL RESEARCH INTO THE CAUSE OF ALZHEIMER'S AND POTENTIAL NEW PHARMACOLIGICAL TREATMENT OPTIONS. THE LAB WAS UNDER THE DIRECTION OF NOBEL LAUREATE DR. PAUL GREENGARD UNTIL APRIL 2019. DR. GREENGARD COLLABORATED WITH SCIENTISTS NATIONALLY AND INTERNATIONALLY TO INVESTIGATE THE LATEST, MOST PROMISING RESEARCH AVAILABLE. THE COLLABORATIONS WILL CONTINUE IN HIS ABSENCE UNDER THE INTERIM LEADERSHIP OF DR. MARC FLAJOLET. THE FISHER CENTER HAS PROVIDED RESEARCHERS WORLDWIDE WITH A CONCEPTUAL FRAMEWORK FOR UNDERSTANDING THE DISEASE PROCESS AND CONTINUES TO BE AT THE FOREFRONT OF ONE DAY FINDING A CURE FOR ALZHEIMER'S DISEASE.A GRANT WAS MADE TO THE ROCKEFELLER UNIVERSITY (RU) IN 2016 TO ESTABLISH THE PAUL GREENGARD PROFESSORSHIP (ESTABLISHED IN PERPETUITY) TO RECOGNIZE DR. PAUL GREENGARD. THIS ENSURES A CONTINUED COMMITMENT TO THE OUTSTANDING RESEARCH BY THE FISHER CENTER FOR ALZHEIMER'S RESEARCH LABORATORY. THE PROFESSORSHIP IS HELD BY AN OUTSTANDING SCIENTIST AT RU WORKING IN THE FIELD OF AD. THE $5 MILLION GRANT IS PAID TO RU OVER SEVEN YEARS.
THE ALZHEIMER'S INFORMATION PROGRAM PROMOTES PUBLIC DISEASE AWARENESS, EDUCATION, AND RESOURCES FOR CAREGIVERS, THROUGH MEDIA CONDUITS, SOCIAL NETWORKS, AND THE INTERNET. THE HEART OF THE PROGRAM IS THE WEBSITE, ALZINFO.ORG, WHICH IS UPDATED REGULARLY TO PROVIDE COMPREHENSIVE DATA ABOUT ALZHEIMER'S DISEASE, RECENT RESEARCH STUDIES AND FINDINGS, TREATMENTS, AND DISEASE MANAGEMENT. THE SITE HAS HAD 556,250 UNIQUE VISITORS AND OFFERS A FREE RESOURCE LOCATOR THAT IDENTIFIES DOCTORS, NURSES, GERIATRIC CAREGIVERS, HOME HEALTH AGENCIES, AND OTHER SOURCES BY ZIP CODE. OUR SCIENTISTS ANSWER QUESTIONS THROUGH AN "ASK THE EXPERTS" PORTAL ON OUR WEBSITE, AND CAREGIVERS CAN JOIN OUR SUPPORT GROUP THROUGH OUR ONLINE CAREGIVER'S CORNER. OUR 1-800-ALZINFO PHONE SYSTEM ASSISTS PEOPLE WHO DO NOT HAVE ACCESS TO THE INTERNET. OUR FREE E-NEWSLETTER, ALZHEIMER'S RESEARCH NEWS YOU CAN USE, IS THE MOST REVIEWED ALZHEIMER'S AND DEMENTIA NEWSLETTER ON THE INTERNET. OUR AWARD WINNING TRIANNUAL PRINT PUBLICATION, "PRESERVING YOUR MEMORY," CIRCULATES 52,000 COPIES PER ISSUE AND HAS REACHED 10.6 MILLION PEOPLE SINCE ITS INCEPTION. THE EDITORIAL CONTENT IS REVIEWED BY OUR SCIENTIFIC TEAM FOR ACCURACY AND VALIDITY AS IT ADDRESSES READERS AFFECTED BY THE DISEASE, WHETHER CAREGIVER OR PATIENT. IT PROVIDES INFORMATION ABOUT ALZHEIMER'S TREATMENT, CARE OPTIONS, AND NECESSARY STEPS TO TAKE AFTER RECEIVING AN ALZHEIMER'S DIAGNOSIS.
A GRANT WAS MADE TO THE NEW YORK UNIVERSITY SCHOOL OF MEDICINE FOR THE FISHER ALZHEIMER'S DISEASE EDUCATION AND RESOURCES PROGRAM WHERE DRS. REISBERG AND KENOWSKY EXAMINED HEALTH OUTCOMES OF THE COMPREHENSIVE, INDIVIDUALIZED, AND PATIENT-CENTERED ALZHEIMER'S MANAGEMENT PROGRAM. PRIMARY RESEARCH FOCUSED ON THE EFFECTS OF THE PROGRAM ON ANTIDEPRESSANT USAGE AND COST. DR. KENOWSKY WILL PRESENT THESE FINDINGS AT THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE IN JULY 2020. THESE RESULTS ARE UNDER EMBARGO UNTIL PRESENTED AT THE CONFERENCE. IN ADDITION, RESEARCH WAS CONDUCTED ON THE RELATIONSHIP BETWEEN BEHAVIORAL DISTURBANCES AND THE PROGRESSION OF PERSONS WITH SUBJECTIVE COGNITIVE DECLINE (SCD).
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Lucretia Holden | EXECUTIVE DIRECTOR | 40 | $165,462 |
| Dr Paul Greengard | TRUSTEE (THRU APR. 2019) | 0.5 | $0 |
| Lois Whitman-Hess | TRUSTEE | 0.5 | $0 |
| Dr Moshe Shike | TRUSTEE | 0.25 | $0 |
| Richard J Salem | TRUSTEE | 0.5 | $0 |
| James L Nederlander | TRUSTEE | 0.25 | $0 |
| Betsy Gotbaum | TRUSTEE | 0.5 | $0 |
| Hadley Fisher | TRUSTEE | 0.5 | $0 |
| Gerry Byrne | TRUSTEE | 0.5 | $0 |
| Dr E Ratcliffe Anderson Jr | TRUSTEE | 0.5 | $0 |
| Dr Manny Alvarez | TRUSTEE | 0.25 | $0 |
| David Hw Turner Trusteethru | 03/2019), SECRETARY (AFTER 03/2019) | 1 | $0 |
| Murray Rubin | SECRETARY (THRU MAR. 2019) | 0.5 | $0 |
| Martin Edelman | VICE CHAIR | 0.25 | $0 |
| Howard Lutnick | VICE CHAIR | 0.25 | $0 |
| Barry R Sloane | CHAIRMAN/TREASURER | 6.75 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202033219349321488_public.xml